MRAI Stock Overview A technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. More details
Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Price History & Performance
Summary of share price highs, lows and changes for Marpai Historical stock prices Current Share Price US$0.98 52 Week High US$2.97 52 Week Low US$0.40 Beta 4.91 1 Month Change -30.81% 3 Month Change 106.02% 1 Year Change -46.89% 3 Year Change -94.61% 5 Year Change n/a Change since IPO -94.83%
Recent News & Updates Marpai, Inc. announced that it expects to receive $0.701949 million in funding Dec 06
Marpai, Inc. to Report Q3, 2024 Results on Nov 12, 2024 Nov 09
Marpai, Inc. to Report Q2, 2024 Results on Aug 07, 2024 Aug 03 Marpai, Inc.(OTCPK:MRAI) dropped from S&P TMI Index May 31
Marpai, Inc.(OTCPK:MRAI) dropped from NASDAQ Composite Index May 30
New major risk - Revenue and earnings growth May 28 See more updates Marpai, Inc. announced that it expects to receive $0.701949 million in funding Dec 06
Marpai, Inc. to Report Q3, 2024 Results on Nov 12, 2024 Nov 09
Marpai, Inc. to Report Q2, 2024 Results on Aug 07, 2024 Aug 03 Marpai, Inc.(OTCPK:MRAI) dropped from S&P TMI Index May 31
Marpai, Inc.(OTCPK:MRAI) dropped from NASDAQ Composite Index May 30
New major risk - Revenue and earnings growth May 28
Independent Director recently sold US$105k worth of stock May 15
Full year 2023 earnings released: US$4.14 loss per share (vs US$5.23 loss in FY 2022) May 12
Consensus revenue estimates decrease by 12%, EPS upgraded May 12
Marpai, Inc. to Report Q1, 2024 Results on May 09, 2024 May 05
Marpai, Inc. Announces Executive Appointments Apr 27 Marpai, Inc. announced that it has received $11.83 million in funding from JGB Management Inc. Apr 17
Revenues Not Telling The Story For Marpai, Inc. (NASDAQ:MRAI) After Shares Rise 30% Apr 07
Full year 2023 earnings: EPS misses analyst expectations Mar 28
Marpai, Inc., Annual General Meeting, May 06, 2024 Mar 16
Nasdaq Panel Grants Marpai's Request for Extension to Comply with Continued Listing Requirements Mar 14
CEO & Director recently bought US$1.5m worth of stock Mar 12 Marpai, Inc. announced that it expects to receive $1.5015 million in funding Mar 09
Marpai, Inc. Provides Impairment Guidance for the Fourth Quarter of 2023
Investors Still Aren't Entirely Convinced By Marpai, Inc.'s (NASDAQ:MRAI) Revenues Despite 34% Price Jump Feb 16 Marpai, Inc. announced that it has received $1.7 million in funding from Libertas Funding, LLC Feb 09
Co-Founder & Chairman of the Board recently bought US$193k worth of stock Jan 18 Marpai, Inc. announced that it expects to receive $1.216464 million in funding Jan 18
Marpai, Inc. Appoints John Powers as President Jan 12
New major risk - Shareholder dilution Dec 19
Market Might Still Lack Some Conviction On Marpai, Inc. (NASDAQ:MRAI) Even After 106% Share Price Boost Dec 19
Co-Founder & Chairman of the Board recently bought US$99k worth of stock Dec 17 Marpai, Inc. announced that it expects to receive $0.2955 million in funding Dec 16
Marpai, Inc. Announces Board Changes Dec 14
Marpai Receives Delisting Notice from Nasdaq Regarding Non-Compliance with the Market Value of Listed Securities Requirement and its Securities to be Delisted from the Nasdaq Capital Market Nov 29
CEO & Director recently bought US$239k worth of stock Nov 24
Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 16
New major risk - Revenue and earnings growth Nov 15
New major risk - Share price stability Nov 11 Marpai, Inc. has withdrawn its Follow-on Equity Offering. Nov 10
Marpai Inc. Announces CEO Changes Nov 07
Marpai Receives Non-Compliance Notice From Nasdaq Oct 07
Marpai, Inc. Executes A Separation Agreement with Mr. Lutz Finger, President of Product and Development Aug 18
New major risk - Market cap size Aug 11
New major risk - Revenue and earnings growth Aug 04 Marpai, Inc. Provides Revenue Guidance for the Third Quarter of 2023
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 04
Marpai, Inc. to Report Q2, 2023 Results on Aug 03, 2023 Jul 29
Consensus EPS estimates upgraded to US$2.40 loss Jul 16
Marpai, Inc. Provides Revenue Guidance for Second Quarter 2023 Jun 30
Marpai Announces Reverse Stock Split in an Effort to Regain Compliance with Nasdaq's Listing Rules Jun 29
Not Many Are Piling Into Marpai, Inc. (NASDAQ:MRAI) Stock Yet As It Plummets 28% Jun 29 Marpai, Inc. Launches Marpai Connect Platform to Predict and Help Modify Risk in Healthcare Jun 02
Marpai, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2023 May 13
Marpai, Inc. Hires Gonen Antebi as Chief Operating Officer Feb 08
Marpai, Inc. Announces Management Changes Feb 02
Marpai Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price Requirement Jan 16
Marpai Introduces Chronic Condition Management to Improve Outcomes for Employer Health Plan Members Jan 06
High number of new and inexperienced directors Nov 16 Marpai, Inc. to Report Q3, 2022 Results on Nov 09, 2022
Director recently bought US$100k worth of stock Sep 15
Marpai Launches MarpaiRx Pharmacy Benefit Management Solution to Decrease Prescription Costs Aug 26
Co-Founder & Chairman of the Board recently bought US$138k worth of stock Aug 19
Marpai rallies after directors buy shares Aug 19
Marpai, Inc. (NasdaqCM:MRAI) signed an agreement to acquire Maestro Health for $22.1 million. Aug 05
Marpai to acquire Maestro Health for $22.1M Aug 04
Marpai, Inc. to Report Q2, 2022 Results on Aug 10, 2022 Aug 03
Co-Founder & Chairman of the Board recently bought US$105k worth of stock May 24
Marpai, Inc. Provides Revenue Guidance for the Second Quarter of 2022 May 12
Marpai, Inc. to Report Q1, 2022 Results on May 11, 2022 May 03 Shareholder Returns MRAI US Insurance US Market 7D -18.1% -1.9% -2.7% 1Y -46.9% 26.1% 23.4%
See full shareholder returns
Return vs Industry: MRAI underperformed the US Insurance industry which returned 26.1% over the past year.
Return vs Market: MRAI underperformed the US Market which returned 23.4% over the past year.
Price Volatility Is MRAI's price volatile compared to industry and market? MRAI volatility MRAI Average Weekly Movement 29.7% Insurance Industry Average Movement 4.2% Market Average Movement 6.3% 10% most volatile stocks in US Market 16.9% 10% least volatile stocks in US Market 3.2%
Stable Share Price: MRAI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MRAI's weekly volatility (30%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.
Show more Marpai, Inc. Fundamentals Summary How do Marpai's earnings and revenue compare to its market cap? MRAI fundamental statistics Market cap US$13.51m Earnings (TTM ) -US$25.96m Revenue (TTM ) US$30.29m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) MRAI income statement (TTM ) Revenue US$30.29m Cost of Revenue US$20.79m Gross Profit US$9.50m Other Expenses US$35.46m Earnings -US$25.96m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -1.89 Gross Margin 31.37% Net Profit Margin -85.70% Debt/Equity Ratio -94.6%
How did MRAI perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/23 08:06 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Marpai, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Allen Klee Maxim Group null null Maxim Group Ashok Kumar ThinkEquity LLC
Show 0 more analysts 
